Young-Mok Kim

Title: Young-Mok Kim: Innovator in Dendritic Cell Research

Introduction

Young-Mok Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunotherapy through his innovative research on dendritic cells. With a total of two patents to his name, Kim's work focuses on enhancing the immune response for therapeutic applications.

Latest Patents

Young-Mok Kim's latest patents include a method for preparing dendritic cells and a composition for maturing these cells. The first patent describes a method that treats dendritic cells at a maturation stage with an antigen bound to a peptide that has cell membrane permeability. This approach aims to improve the antigen-presenting ability of dendritic cells, making them more effective for use in anti-tumor vaccines and pharmaceutical compositions for treating tumors. The second patent outlines a composition for maturing dendritic cells, which includes various maturation-promoting factors such as Interleukin-1β, Interleukin-6, and Tumor necrosis factor-α. This composition is designed to enhance the ability of dendritic cells to induce a specific immune response while minimizing non-specific responses.

Career Highlights

Young-Mok Kim is currently associated with Jw Creagene Inc., where he continues to advance his research in immunotherapy. His innovative approaches have positioned him as a key figure in the development of new therapeutic strategies for cancer treatment.

Collaborations

Throughout his career, Young-Mok Kim has collaborated with notable colleagues, including Seung-Soo Han and Yong-Soo Bae. These collaborations have further enriched his research and contributed to the advancement of dendritic cell therapies.

Conclusion

Young-Mok Kim's contributions to dendritic cell research and immunotherapy highlight his role as an influential inventor in the field. His innovative patents and ongoing work continue to pave the way for new therapeutic options in cancer treatment.